SNAI1 and neoplasm: Expression of proteins that are characteristic of mesenchymal cells (e.g. vimentin, FSP1/S100A4, SNAI1, SNAI2, and stromelysin-3) and loss of epithelial markers (e.g. E-cadherin) correlates with tumor progression and poor prognosis [17].